Design, Synthesis, and Anti-Hepatocellular Carcinoma Evaluation of Sesquiterpene Lactone Epimers Trilobolide-6-O-isobutyrate Analogs
Molecules · 2024
DOI: 10.3390/molecules29020393 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Xiuqiao Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Tropical Medicinal Resource Chemistry of Ministry of Education, College of Chemistry and Chemical Engineering, Hainan Normal Univer…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Sesquiterpenes, Butyrates. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wen-Hao Chen, Yang Hui, Guang-Ying Chen.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC), one of the most common malignant cancers with a low 5-year survival rate, is the third leading cause of cancer-related deaths worldwide. The finding of novel agents and strategies for the treatment of HCC is an urgent need. Sesquiterpene lactones (SLs) have attracted extensive attention because of their potent antitumor activity. In this study, a new series of SL derivatives (3–18) were synthesized using epimers 1 and 2 as parent molecules, isolated from Sphagneticola trilobata, and evaluated for their anti-HCC activity. Furthermore, the structures of 4, 6, and 14 were confirmed by X-ray single-crystal diffraction analyses. The cytotoxic activities of 3–18 on two HCC cell lines, including HepG2 and Huh7, were evaluated using the CCK-8 assay. Among them, compound 10 exhibited the best activity against the HepG2 and Huh7 cell lines. Further studies showed that 10 induced cell apoptosis, arrested the cell cycle at the S phase, and induced the inhibition of cell proliferation and migration in HepG2 and Huh7. In addition, absorption, distribution, metabolism, and excretion (ADME) properties prediction showed that 10 may possess the properties to be a drug candidate. Thus, 10 may be a promising lead compound for the treatment of HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Tropical Medicinal Resource Chemistry of Ministry of Education, College of Chemistry and Chemical Engineering, Hainan Normal University, Haikou 571158, China.
- Key Laboratory of Tropical Medicinal Plant Chemistry of Hainan Province, College of Chemistry and Chemical Engineering, Hainan Normal University, Haikou 571158, China.
- Public Research Center, Hainan Medical University, Haikou 571199, China.
Förderung
- Wen-Hao Chen
- Yang Hui
- Guang-Ying Chen
- National Natural Science Foundation of China
- Key Project of Research and Development of Hainan Province
- Hainan Provincial Natural Science Foundation of China
- Specific Research Fund of the Innovation Platform for Academicians of Hainan Province
Zitieren
APA
Zhou, X., Yi, G., Qian, Y., Yang, X., Chen, G., Hui, Y., & Chen, W. (2024). Design, Synthesis, and Anti-Hepatocellular Carcinoma Evaluation of Sesquiterpene Lactone Epimers Trilobolide-6-O-isobutyrate Analogs. Molecules. https://doi.org/10.3390/molecules29020393
Vancouver
Zhou X, Yi G, Qian Y, Yang X, Chen G, Hui Y, et al. Design, Synthesis, and Anti-Hepatocellular Carcinoma Evaluation of Sesquiterpene Lactone Epimers Trilobolide-6-O-isobutyrate Analogs. Molecules. 2024. doi:10.3390/molecules29020393
BibTeX
@article{Zhou2024,
author = {Zhou, Xiuqiao and Yi, Guohui and Qian, Yiming and Yang, Xiaorong and Chen, Guangying and Hui, Yang and Chen, Wenhao},
title = {Design, Synthesis, and Anti-Hepatocellular Carcinoma Evaluation of Sesquiterpene Lactone Epimers Trilobolide-6-O-isobutyrate Analogs},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29020393}
}
EUVIMED